BioSpace News Archive

BioMidwest

Nexus Pharmaceuticals Receives Patent for EMERPHED® Ready-To-Use Ephedrine Sulfate Injection

Nexus Pharmaceuticals Receives Patent for EMERPHED ® Ready-To-Use Ephedrine Sulfate Injection

August 17, 2021
·
3 min read
Orthopedic Implants Market Opportunities, Challenges, Drivers, Growth, Countries, Revenue, and Forecast to 2028

Orthopedic implants are surgically placed inside the body to replace or support a missing or damaged bone or joint.

August 17, 2021
·
4 min read
Protein Binding Assay Market: Growing Drug Discovery Activities Drive Protein Binding Assay Market Growth

The protein binding assay market is projected to reach US$ 694.63 million by 2028 from US$ 340.14 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.

August 17, 2021
·
5 min read
BioMidwest

Dr. David Nash, Katherine Capps to Headline hc1’s 2021 Precision Health Virtual Summit

hc1 announced today that Katherine Capps and David Nash , MD, MBA, will deliver the mainstage keynote addresses at its second annual Precision Health Virtual Summit

August 17, 2021
·
4 min read
Cancer Immunotherapy Market Size to Grow $309.66 Billion and registering at a CAGR 14.1% by 2030

Flood in rate of malignancies around the world, development in geriatric populace, and ascend in disease R&D are expected to help the market acquire footing during the figure time frame.

August 17, 2021
·
4 min read
Pain Management Devices Market Worth To Reach $5.76 Billion By 2028 with CAGR of 6.3%

Increase in prevalence of chronic diseases, rise in R&D investments, and launch of innovative products drive the growth of the global pain management devices market.

August 17, 2021
·
5 min read
Biotech Bay

A New Approach to Curing HIV

Over the last 40 years, HIV has shifted from a deadly and mysterious virus to one that can be controlled with daily drugs. But attempts to completely eliminate the virus from the bodies of people living with HIV, curing them for good, have failed.

August 17, 2021
·
10 min read
Business

Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of CUE-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights

Cue Biopharma, Inc. provided a business and clinical progress update for the second quarter 2021.

August 17, 2021
·
7 min read
Aequus and reVision to Collaborate on Stargardt Disease Program

Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. announce a collaboration on the development of a therapy for Stargardt disease.

August 17, 2021
·
7 min read
Biotech Bay

Karius receives New York State permit for its liquid biopsy test to detect infectious diseases

Karius has received approval from the New York State Department of Health’s Clinical Laboratory Evaluation Program (CLEP) for its Karius Test for pathogen detection.

August 17, 2021
·
2 min read